The African Democratic Congress, ADC, has warned its supporters against what it described as a “must-be-my-candidate” mindset. The National Publicity Secretary of the party, Bola Abdullahi, gave the ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a deal that could be worth up to £268 million ($358 million). The object of ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

THOSE who heard Prof. Southwell's lecture to the London Mathematical Society in 1937 will well remember how he communicated to his audience some of the great enthusiasm with which he had reacted to ...

With our homes and lives swarming with AI-powered devices, assistants and chatbots, a backlash is brewing. Pitched as “analog lifestyles,” it’s different than a short-term digital detox. Instead, it’s ...

Delay lines bridge abstract timing concepts with hands-on engineering solutions in communications, signal conditioning, and test systems.

A line of shoppers is often seen outside the Andersonville stationery shop Paper & Pencil. At the front of the line, a store employee acts as a bouncer — preventing overcrowding in the 400-square-foot ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.